Renal Hypophosphatemic Rickets

  • James C. M. Chan
  • Uri Alon
Part of the Developments in Nephrology book series (DINE, volume 11)


Renal hyponhosphatemic rickets is a renal tubular disorder which has fascinated workers in the field for a long time (1–7). The condition is concurrently known as sex-linked dominant hypophosphatemic rickets, vitamin D resistant rickets and familial hypophosphatemia. Recent advances in phosphate metabolism, pathophysiology, and treatment will be reviewed here.


Tubular Reabsorption Hypophosphatemic Rickets Serum Phosphate Concentration Renal Tubular Disorder Resistant Rickets 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McEnery PT, Silverman FN, West CD: Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets. J Pediatr 80:763, 1972.PubMedCrossRefGoogle Scholar
  2. 2.
    Stickler GB, Jowsey J, Bianco AJ: Possible detrimental effects of large doses of vitamin D in familial hypophosphatemic vitamin D-resistant rickets. J Pediatr 79:68, 1971.PubMedCrossRefGoogle Scholar
  3. 3.
    Field MH, Reiss E: Vitamin D-resistant rickets: The effect of calcium infusion on phosphate reabsorption. J Clin Invest 39:1807, 1960.PubMedCrossRefGoogle Scholar
  4. 4.
    Falls WF Jr, Carter NW, Rector FC Jr, et al: Familial vitamin-D-resistant rickets: Study of six cases with evaluation of the pathogenic role of secondary hypoparathyroidism. Ann Int Med 68:553, 1968.PubMedGoogle Scholar
  5. 5.
    Fraser D, Leeming JM, Cerwenka EA, Kenyeres K: Studies of the pathogenesis of the high renal clearance of phosphate in hypophosphatemic vitamin Drefractory rickets of the simple type. Am J Dis Child 98:586, 1959.Google Scholar
  6. 6.
    Blackard WG, Robinson RR, White JE: Familial hypophosphatemic report of a case with observations regarding pathogenesis. N Engl J Med 266:899, 1962.PubMedCrossRefGoogle Scholar
  7. 7.
    Arnstein AR, Hanson CA: Nature of renal phosphate leak. N Engl J Med 281:1427, 1969.PubMedGoogle Scholar
  8. 8.
    Harrison HE, Harrison HC: Disorders of calcium and phosphate metabolism in childhood and adolescence. Philadelphia, 1979, W. B. Saunders.Google Scholar
  9. 9.
    Scriver CR: Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes. Am J Med 57:43, 1974.PubMedCrossRefGoogle Scholar
  10. 10.
    Alon U, Chan JCM: Effects of PTH and l,25(OH)2D3 on tubular handling of phosphate in hypophosphatemic rickets. J Clin Endocrinol Metabol 58:681, 1984.CrossRefGoogle Scholar
  11. 11.
    Kruse K, Kracht U, Gopfert G: Renal threshold phosphate concentration (TmPO4/GFR). Arch Dis child 57:217, 1982.PubMedCrossRefGoogle Scholar
  12. 12.
    Glorieux FH, Scriver CR: Transport, metabolism and clinical use of inorganic phosphate in X-linked hypophosphatemia. In Frame B, Parfitt AM, Duncan H, editors: The clinical aspects of metabolic bone disease. Amsterdam, 1973, Excerpta Medica ICS, p 421.Google Scholar
  13. 13.
    Rasmussen H, Anast C: Familial hypophosphatemic rickets and vitamin-D dependent rickets. In Stanbury JB, Wyngaarden JB, Frederickson DS, et al, editors: The metabolic basis of inherited disease, ed. 5, New York, 1983, McGraw-Hill, p 1743.Google Scholar
  14. 14.
    Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH: A genetic study of familial hypophosphatemic and vitamin D-resistant rickets with a review of the literature. Medicine 37:97, 1958.PubMedCrossRefGoogle Scholar
  15. 15.
    Balsam S, Garabedian M, Gorgniard R, Holick MF, DeLuca HF: 1,25-dihydroxyvitamin-D3 and 1 alpha-hydroxyvitamin-D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance. Pediatr Res 9:586, 1975.Google Scholar
  16. 16.
    Burnett CH, Dent CE, Harper C, Warland BJ: Vitamin D-resistant rickets: Analysis of 24 pedigrees with hereditary and sporadic cases. Am J Med 36:222, 1964.PubMedCrossRefGoogle Scholar
  17. 17.
    Chesney RW, Mazess RB, Rose P, et al: Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D. Am J Dis Child 134:140, 1980.PubMedGoogle Scholar
  18. 18.
    Mason RS, Rohl PG, Lissner D, Posen S: Vitamin D metabolism in hypophosphatemic rickets. Am J Dis Child 136:909, 1982.PubMedGoogle Scholar
  19. 19.
    Lyles KW, Clark AG, Drezner MK: Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia. Calcif Tissue Int 34:125, 1982.PubMedCrossRefGoogle Scholar
  20. 20.
    Tenenhouse HS: Abnormal mitochondrial 25-hydroxyvitamin D3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse. Endocrinology 113:816, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Hirschman GH, DeLuca HF, Chan JCM: Hypophosphatemic vitamin D-resistant rickets: Metabolic balance studies in a child receiving 1,25-dihydroxyvitamin-D3, phosphate and ascorbic acid. Pediatrics 61:451, 1978.PubMedGoogle Scholar
  22. 22.
    Chan JCM, Bartter FC: Hypophosphatemic rickets: Effect of lα, 25-dihydroxyvitamin-D3 on growth and mineral metabolism. Pediatrics 64:488, 1979.PubMedGoogle Scholar
  23. 23.
    Chan JCM, Lovinger RD, Mamunes P: Renal hypophosphatemic rickets: Growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3. Pediatrics 66:445, 1980.PubMedGoogle Scholar
  24. 24.
    Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE: Long-term treatment of familial hypophosphatemic rickets with oral phosphate and lα-hydroxyvitamin-D3. J Pediatr 99:16, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE: Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023, 1980.PubMedCrossRefGoogle Scholar
  26. 26.
    Chesney RW, Mazess RB, DeLuca HF: Long-term influences of calcitriol and supplemental phosphate in X-linked hypophosphatemic rickets. Calcif Tissue Int 33:307, 1981.Google Scholar
  27. 27.
    Kristiansen JH, Pedersen VF: Hypophosphatemic vitamin D-resistant rickets treated with lα-hydroxyvitamin-D. Int J Ped Nephr 2:245, 1981.Google Scholar
  28. 28.
    Russeil RGG, Smith R, Preston C, Walton RJ, Woods CG, Henderson RG, Norman AW: The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphatemic renal tubular rickets. Clin Sci Mol Med 48:177, 1975.Google Scholar
  29. 29.
    West CD, Blanton JC, Silverman FN, et al: Use of phosphate salts as an adjunct to vitamin D in the treatment of hypophosphatemic vitamin D-refractory rickets. J Pediatr 64:469, 1964.PubMedCrossRefGoogle Scholar
  30. 30.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM: Evaluation of a role for 1,25-dihydroxyvitamin-D in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest 66:1020, 1980.PubMedCrossRefGoogle Scholar
  31. 31.
    Alon U, Chan JCM; Thiazides as adjuvant therapy in X-linked dominant renal hypophosphatemic rickets. 67th annual meeting of the Feder Am Soc Exp Biol (Chicago, April 1983).Google Scholar
  32. 32.
    Alon U, Costanze LS, Chan JCM: Additive hypocalciuric effects of amiloride and hydrochlorothiazide in patients treated with calcitriol. Min Electrolyte Metabl 10:379, 1984.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • James C. M. Chan
  • Uri Alon

There are no affiliations available

Personalised recommendations